{
    "Trade/Device Name(s)": [
        "BD Directigen EZ Flu A+B test",
        "BD DirectigenTM EZ Flu A+B test",
        "Directigen EZ Flu A+B test",
        "Directigen TM EZ Flu A+B test"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K101461",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063689",
        "K042472",
        "K101529"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "May 24, 2010",
    "Summary Letter Received Date": "May 26, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral antigen",
        "Influenza B viral antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal wash/aspirate",
        "Nasopharyngeal swab",
        "Throat swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay"
    ],
    "Methodologies": [
        "Qualitative antigen detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BD Directigen EZ Flu A+B test, a chromatographic immunoassay for qualitative detection of influenza A and B antigens in respiratory samples",
    "Indications for Use Summary": "Rapid chromatographic immunoassay to directly and qualitatively detect influenza A and B viral antigens from respiratory specimens of symptomatic patients as an aid in diagnosing influenza A and B infections, with negative results to be confirmed by cell culture",
    "fda_folder": "Microbiology"
}